Dompe Announces Innovative Treatment in the Fight Against Type 1 Diabetes: Pancreatic Islet Cell Transplantation, a Hope That Has Already Come True
7/11/2013 10:14:13 AM
Get the latest biotech news where you want it. Sign up for the free
GenePool newsletter today!
MILAN--(BUSINESS WIRE)--Pancreatic islets, containing insulin-producing cells, are isolated from a donor's pancreas and implanted in the liver of the recipient through a simple infusion procedure. Once in place, the transplanted islets begin to produce insulin. This is the mechanism of action of pancreatic islet transplantation, now a reality for those suffering from type 1 diabetes and in particular from the so-called "brittle diabetes", or unstable diabetes, an uncontrolled disease despite medications. To ensure the results of this innovative approach, however, it is necessary to protect the pancreatic islets that are attacked by the immune system of the recipient.
Help employers find you! Check out all the jobs and post your resume.
comments powered by